COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders

BACKGROUND: Neurologic outcomes in patients with multiple sclerosis (MS) and related disorders (MSRD) following COVID-19 is not well understood. The objective of this study was to investigate neurologic outcomes in patients with MSRD post-COVID-19. METHODS: This was a retrospective medical records r...

Descripción completa

Detalles Bibliográficos
Autores principales: Conway, Sarah E., Healy, Brian C., Zurawski, Jonathan, Severson, Christopher, Kaplan, Tamara, Stazzone, Lynn, Galetta, Kristin, Chitnis, Tanuja, Houtchens, Maria K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556032/
https://www.ncbi.nlm.nih.gov/pubmed/35709663
http://dx.doi.org/10.1016/j.msard.2022.103946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556032/
https://www.ncbi.nlm.nih.gov/pubmed/35709663
http://dx.doi.org/10.1016/j.msard.2022.103946

Ejemplares similares